Artechmed

Artechmed is a medical device and equipment developer dedicated to the research, development, and production of minimally invasive interventional devices for treating atrial fibrillation. Its cryoballoon ablation technology offers advantages such as a short learning curve, simple surgical procedures, high safety, and minimal complications. The company’s first product, a minimally invasive cryoablation system for atrial fibrillation, has entered the clinical trial stage. Additionally, Artechmed plans to expand its innovative product pipeline for atrial fibrillation treatment, apply for CE and FDA certifications, and enter the international market.